Indonesia

Flag of Indonesia

The health security context in Indonesia is challenging, including a large, geographically and socially diverse population, decentralised administration, and vulnerability to natural disasters. Indonesia is considered a ‘hot spot’ for emerging infectious diseases. Tuberculosis is the fourth leading cause of death, and there are continuing outbreaks of vaccine preventable illness (measles, diphtheria), and diseases spread from animals to humans (zoonoses) such as anthrax, leptospirosis and rabies.

Indonesia underwent a Joint External Evaluation (JEE) in November 2017 and World Organisation for Animal Health (OIE) reviews of veterinary services in 2007 and 2010. Indonesia is now finalising a National Action Plan for Health Security, to provide a framework for implementing JEE recommendations.

The Centre for Health Security has planned a series of investments to address gaps noted in the assessments, as well as recommendations made by the scoping mission, commissioned by the Centre for Health Security in 2018.

 

In March 2019, DFAT opened a call for proposals under the Health Security Initiative for country-specific and multi-country activities to strengthen infectious disease detection, prevention and response in the Indo-Pacific region. Two streams of funding have been established:

  • The Pacific Infectious Disease Prevention (PIDP) program - $25 million over 2019-2022.
  • The ASEAN-Pacific Infectious Disease Detection and Response (APIDDaR) program - $28 million over 2019-2022.

As at November 2019, the Centre for Health Security is undertaking a collaborative design process with a group of preferred partner organisations, who were selected on the basis is demonstrated organisational capacity and activity concepts.

Country & Regional

  • The Indo-Pacific Regulatory Strengthening Program

    Supporting national medicines regulatory authorities to work together effectively improves the impact and safety of medical products through more efficient regulation. To this end, Australia’s Therapeutic Goods Administration is working with key Indo-Pacific counterpart authorities to improve regulatory systems and processes, including through sharing regulatory information.

  • Australian Animal Health Laboratory (AAHL) Twinning Program

    CSIRO’s Australian Animal Health Laboratory (AAHL) has longstanding experience and expertise in detecting animal health diseases in the Indo-Pacific. This program enables AAHL to share expertise and resources through twinning arrangements with laboratories in Indonesia and Myanmar, and through regional capacity building activities.

  • World Mosquito Program

    DFAT supports the World Mosquito Program (WMP) to trial the use of Wolbachia bacteria to reduce the transmission of the dengue virus, as well as other arboviruses including Zika and chikungunya, in several countries in the Pacific and Southeast Asia. 

  • Asia Pacific Leaders Malaria Alliance (APLMA)

    A high-level initiative for collective action to eliminate malaria across Asia and the Pacific by 2030. The APLMA/APMEN Secretariat delivers its objectives through advocacy and outreach; fostering and strengthening partnerships and innovation; and providing policy guidance.